Antithrombotic Treatments in Patients with Chronic Coronary Artery Disease or Peripheral Artery Disease: A Systematic Review of Randomised Controlled Trials

AIMS: Acetylsalicylic acid (ASA) is widely used for the prevention of atherothrombotic events in patients with chronic coronary artery disease (CAD) and peripheral artery disease (PAD), but the risk of vascular events remains high. We aimed at identifying randomised controlled trials (RCTs) on antit...

Descripción completa

Detalles Bibliográficos
Autores principales: Bauersachs, Rupert, Wu, Olivia, Briere, Jean-Baptiste, Bowrin, Kevin, Borkowska, Katarzyna, Jakubowska, Anna, Taieb, Vanessa, Toumi, Mondher, Huelsebeck, Maria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2020
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7345917/
https://www.ncbi.nlm.nih.gov/pubmed/32695228
http://dx.doi.org/10.1155/2020/3057168

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7345917/
https://www.ncbi.nlm.nih.gov/pubmed/32695228
http://dx.doi.org/10.1155/2020/3057168

Ejemplares similares